object
systemat
review
identifi
prognost
factor
potenti
use
decisionmak
relat
care
patient
infect
protocol
live
systemat
review
follow
common
protocol
multipl
parallel
systemat
review
alreadi
publish
submit
prospero
await
id
alloc
includ
studi
assess
patient
confirm
suspect
infect
inform
relat
potenti
prognost
factor
death
diseas
sever
two
group
two
review
independ
screen
studi
elig
extract
data
assess
risk
bia
perform
metaanalys
use
grade
assess
certainti
evid
prognost
factor
outcom
live
webbas
version
review
openli
avail
pandem
resubmit
conclus
chang
substanti
updat
ethic
approv
consid
necessari
result
review
wide
dissemin
via
peerreview
public
social
network
tradit
media
infect
caus
coronaviru
first
identifi
wuhan
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
china
decemb
three
month
later
almost
half
million
case
contagion
identifi
across
countri
march
characteris
outbreak
pandem
major
case
result
mild
symptom
might
progress
pneumonia
acut
respiratori
distress
syndrom
death
case
fatal
rate
report
across
countri
set
age
group
highli
variabl
would
rang
hospit
patient
report
higher
centr
prognost
factor
standalon
combin
risk
assess
model
employ
patient
infect
stratifi
differ
subset
patient
risk
develop
sever
diseas
die
stratif
may
support
optimis
manag
resourc
util
strategi
provid
care
patient
although
multipl
prognost
factor
propos
accept
establish
scientif
commun
ie
age
predict
capac
potenti
prognost
factor
properli
evalu
remain
uncertain
use
innov
agil
process
take
advantag
technolog
tool
resort
collect
effort
sever
research
group
live
systemat
review
aim
provid
time
rigor
continu
updat
summari
evid
avail
prognost
factor
potenti
use
decisionmak
relat
care
patient
infect
manuscript
compli
prefer
report
item
systemat
review
metaanalys
prisma
guidelin
report
systemat
review
metaanalys
addit
follow
charmpf
checklist
determin
item
extract
primari
studi
prognost
factor
protocol
state
share
object
methodolog
multipl
evid
synthes
systemat
review
overview
systemat
review
conduct
parallel
differ
question
relev
regist
prospero
submit
await
prospero
id
alloc
publish
protocol
adapt
specif
question
assess
review
literatur
search
devis
team
maintain
platform
http
appiloveevidencecom
use
follow
approach
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
identif
term
relev
popul
intervent
compon
search
strategi
use
technolog
corpu
document
avail
epistemoniko
databas
discuss
term
content
method
expert
identifi
relev
irrelev
miss
term
creation
sensit
boolean
strategi
encompass
relev
term
iter
analysi
articl
miss
boolean
strategi
refin
strategi
accordingli
main
search
sourc
epistemoniko
databas
http
wwwepistemonikosorg
comprehens
databas
systemat
review
type
evid
supplement
articl
multipl
sourc
relev
without
studi
design
public
statu
languag
restrict
sum
epistemoniko
databas
act
central
repositori
articl
fulfil
epistemoniko
criteria
visibl
user
remain
articl
access
member
work
group
addit
search
conduct
use
highli
sensit
search
pubmedmedlin
cochran
central
regist
control
trial
central
embas
without
languag
public
statu
restrict
search
cover
incept
date
databas
day
submiss
follow
strategi
use
search
epistemoniko
databas
adapt
syntax
databas
coronavir
coronoviru
corona
viru
viru
corona
corono
viru
viru
corono
hcov
covid
cv
ncov
ncov
wuhan
viru
virus
viral
covid
viru
virus
viral
sarscov
sar
cov
sarscoronaviru
sever
acut
respiratori
syndrom
merscov
mer
cov
middl
east
respiratori
syndrom
middleeast
respiratori
syndrom
ncovrel
incid
followup
follow
progno
predict
cours
order
identifi
articl
might
miss
electron
search
follow
screen
refer
list
systemat
review
evalu
full
text
articl
includ
scan
refer
list
select
guidelin
narr
review
document
conduct
crosscit
search
googl
scholar
microsoft
academ
use
includ
studi
index
refer
review
refer
list
includ
studi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
includ
prognost
factor
risk
assess
model
studi
base
typolog
prognosi
propos
iorio
colleagu
base
prognosi
research
strategi
progress
group
framework
exclud
studi
evalu
effect
anim
model
vitro
condit
includ
studi
evalu
patient
confirm
infect
independ
healthcar
set
ie
ambulatori
inpati
sever
infect
exclud
studi
popul
reflect
gener
popul
interest
studi
includ
patient
viral
infect
eg
sarscov
merscov
investig
prognost
factor
report
individu
studi
compar
patient
expos
patient
unexpos
one
factor
explor
prognost
inform
provid
everi
prognost
factor
independ
establish
prognost
factor
age
comorbid
diseas
sever
start
follow
use
outcom
exclus
criteria
select
process
articl
meet
criteria
except
outcom
criterion
preliminarili
includ
evalu
full
text
includ
studi
assess
mortal
sever
infect
accept
author
definit
sever
infect
addit
consid
outcom
assum
reflect
sever
ie
icu
requir
consid
studi
provid
inform
prognost
factor
measur
time
infect
confirm
independ
healthcar
set
outpati
gener
ward
icu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
result
literatur
search
epistemoniko
databas
automat
incorpor
platform
autom
retriev
dedupl
algorithm
compar
uniqu
identifi
databas
id
doi
trial
registri
id
citat
detail
ie
author
name
journal
year
public
volum
number
page
articl
titl
articl
abstract
addit
search
upload
screen
softwar
platform
two
research
independ
screen
titl
abstract
yield
search
inclus
criteria
obtain
full
report
titl
appear
meet
inclus
criteria
requir
analysi
decid
inclus
record
reason
exclud
trial
stage
search
outlin
studi
select
process
prisma
flow
diagram
adapt
purpos
project
two
review
ai
mr
screen
independ
duplic
titl
abstract
retriev
citat
discrep
resolv
consensu
retriev
full
text
citat
judg
potenti
elig
two
team
two
review
aiv
mrft
screen
full
text
independ
duplic
compar
result
disagr
resolv
consensu
review
use
standard
screen
form
conduct
calibr
exercis
screen
process
two
group
two
review
abstract
data
independ
duplic
elig
studi
use
standard
form
review
compar
discuss
result
case
disagr
conduct
calibr
exercis
pilot
form
prior
start
data
abstract
process
identifi
studi
risk
assess
model
studi
prognost
factor
studi
review
abstract
data
follow
characterist
studi
context
eg
countri
year
public
studi
design
eg
cohort
case
control
durat
follow
popul
demograph
eg
sampl
size
age
number
center
outcom
definit
method
measur
time
occurr
miss
inform
prognost
factor
definit
measur
method
includ
threshold
use
continu
predictor
measur
associ
eg
odd
ratio
crude
estim
calcul
number
patient
expos
nonexpos
without
event
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
two
review
independ
duplic
assess
risk
bia
individu
includ
studi
discrep
resolv
consensu
assess
risk
bia
includ
studi
use
qualiti
prognosi
studi
tool
quip
prognost
factor
studi
order
assess
adequaci
multivari
model
use
adjust
effect
estim
consid
appropri
model
includ
follow
age
one
comorbid
ie
diabet
one
paramet
diseas
sever
ie
disphnea
everi
individu
prognost
factor
present
measur
associ
correspond
outcom
present
effect
estim
odd
ratio
or
correspond
confid
interv
ci
studi
report
measur
associ
hazard
ratio
hr
risk
ratio
rr
convert
or
use
baselin
risk
death
rate
incid
sever
infect
total
sampl
report
studi
use
crude
effect
estim
adjust
estim
provid
present
result
includ
studi
includ
individu
prognost
factor
tabular
narr
format
standard
unit
measur
prognost
factor
unifi
direct
predictor
adjust
weight
studi
calcul
crude
effect
estim
provid
possibl
metaanalyz
prognost
factor
associ
outcom
mortal
sever
infect
report
one
studi
use
gener
invers
variancebas
method
produc
overal
measur
associ
explor
consist
associ
metaanalyz
result
studi
report
predictor
could
pool
use
randomeffect
model
provid
metafor
packag
r
softwar
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
explor
robust
estim
effect
everi
prognost
factor
everi
outcom
perform
follow
addit
analysi
subgroup
analysi
perform
subgroup
analysi
accord
definit
sever
infect
ie
respiratori
failur
vs
respiratori
distress
syndrom
vs
icu
requir
case
identifi
signific
differ
subgroup
test
interact
report
result
individu
subgroup
separ
sensit
analysi
perform
sensit
analysi
exclud
high
risk
bia
studi
studi
report
adjust
estim
case
effect
estim
provid
primari
analysi
sensit
analysi
significantli
differ
either
present
low
risk
biasadjust
estim
present
primari
analysi
estim
rate
certainti
evid
risk
bia
necessari
perform
subgroup
sensit
analys
account
altern
way
prognost
factorsoutcom
measur
present
everi
individu
prognost
factor
present
measur
associ
correspond
outcom
perform
assess
certainti
evid
prognost
factor
per
outcom
base
grade
approach
approach
consid
follow
domain
risk
bia
indirect
inconsist
imprecis
public
bia
develop
summari
find
tabl
rate
overal
certainti
evid
high
moder
low
low
depend
grade
individu
domain
artifici
intellig
algorithm
deploy
topic
platform
http
provid
instant
notif
articl
high
likelihood
elig
author
review
decid
upon
inclus
updat
live
web
version
review
accordingli
consid
resubmiss
journal
chang
direct
effect
critic
outcom
substanti
modif
certainti
evid
review
part
larger
project
set
produc
multipl
parallel
systemat
review
relev
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
project
commiss
organis
receiv
extern
fund
epistemoniko
foundat
provid
train
support
tool
cost
member
work
group
protocol
submit
await
prospero
id
alloc
research
access
inform
could
lead
identif
individu
particip
obtain
ethic
approv
waiv
data
relat
project
avail
epistemoniko
foundat
grant
access
data
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
